EPO-4-Rhesus Study

Clinical trial NCT03104426 · UNKNOWN

Trial details

NCT number: NCT03104426
Sponsor: Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Erythroblastosis, Fetal Erythroblastosis Fetalis, Rh Disease Erythroblastosis Fetalis Due to RH Antibodies Erythroblastosis Fetalis Due to Isoimmunization

Start date: 2017-10-31
Primary completion: 2020-08-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.